NICOLE MIKULA: Open Payments
NPI 1598223174 · APALACHIN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,407 in 94 payments from 12 companies in 2025. Trend: 2023 $758 · 2024 $1,268 · 2025 $2,407
Food & beverage: $2,302Education: $104
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $720 |
| Neurocrine BioSciences, Inc. | 36 | $557 |
| Alkermes, Inc. | 6 | $234 |
| Teva Pharmaceuticals USA, Inc. | 7 | $190 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $162 |
| Braeburn Inc. | 1 | $130 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 3 | $84 |
| Janssen Pharmaceuticals, Inc | 2 | $83 |
| E.R. Squibb & Sons, L.L.C. | 4 | $68 |
Products named: VRAYLAR, INGREZZA, CAPLYTA, BRIXADI, FANAPT, LYBALVI, ARISTADA, SPRAVATO.
Industry payments across NY — which companies pay providers there.
